Please assess the completion status of the following clinical trial:

Trial Title: Macular Pigment and Glare Disability

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Gender: male or female~* Age: 18 - 40 years~* BMI: 20-30~* No anticipated changes in dieting habits (as relevant to xanthophyll intake).~* No anticipated surgical procedures.~* Assessed as healthy, based on a pre-study examination including medical history, physical examination, and clinical laboratory. The examination will be performed by an MD or a Nurse Practitioner.~* Willingness and ability to give written informed consent and willingness and ability to comply with the study requirements.~* Corrected visual acuity (ETDRS): better than 20/60~Exclusion Criteria:~* BMI \<20 or \>30~* Age \<18 or \>40 years~* Smokers~* Current or history of relevant diseases (such as AMD)~* Corrected visual acuity worse than 20/60~* Inability to reliably perform MPOD measurements by heterochromatic flicker photometry or any of the other ophthalmic tests of the study.~* Any condition likely to interfere with normal gastro-intestinal absorption of xanthophylls.~* Current use of xanthophyll containing supplements~* Use of xanthophyll containing supplements in the past 6 months~* Participation in any other study during last 1 month.~* Blood donation during the last 3 months.~* Known hypersensitivity or allergy to xanthophylls.~* Regular intake of medications or supplements, which the principal investigator deems likely to confound the study outcomes.~* Suspected lack of compliance with any requirements of the study.~* Childbearing potential and unwillingness to refrain from acceptable anticonceptive measures (not including abstinence).~* Current pregnancy or breast feeding~* Any relevant abnormalities in the routine laboratory tests

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Intervention (Type: ACTIVE_COMPARATOR): 10 mg FloraGlo lutein + 2 mg Optisharp zeaxanthin
- Placebo (Type: PLACEBO_COMPARATOR): visually identical placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).